Company page

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc (ticker: AUPH) is a public company based in America, focused on developing innovative therapies for kidney diseases. With a market capitalization of approximately $2.12 billion, Aurinia is dedicated to advancing its research and product pipeline to address unmet medical needs in the field. The company aims to improve patient outcomes through its commitment to scientific innovation and clinical development.